|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Long-term outcomes following drug-eluting stent implantation in unprotected left main bifurcation lesions显示文摘背景 drug-eluting stents (DES ) 的安全和功效培植在没有防卫留给主要(LM ) 分叉损害还得被决定。现在的报告的目的是在我们识别了的没有防卫的 LM 分叉 lesions.Methods 评估 DES 的长期的结果追随者培植从 4 月 2003to 日 2005 年 1 月在没有防卫的 LM 分叉损害与 DES 对待的 70 个连续病人。他们, 42 个病人与 sirolimus-eluting stent (SES ) 被对待, 28 个病人与 paclitaxel-eluting stent (足) 被对待 .Results Stents 到左前面的下降并且到降声调符号在 62 个病人被植入。在 1 年的后续期间, 3 (4.3%) 病人们死于心脏的原因。他们之一有心肌的梗塞并且是判决了可能由于 stent 血栓。Angiographic 后续在 80% 病人是可得到的。per 损害狭窄率在全部队, 10.7% 在与 SES 对待的损害发生了是 13.4% , 16.1% 与足(P=0.58 ) 在那些对待。所有狭窄在与 stent 尺寸与 stent 对待到 procedural 以后参考容器直径比率 1.0 的损害焦点、发生(17.6% 对 0, P=0.04 ) 。在 1 年的 per 病人目标损害 revascularization 率是 17.1% 。从主要不利心脏的事件免费的一年幸存是用 DES 的 LM 分叉损害的 77.1%.Conclusions 治疗是有对在对改进的 17% 病人要求的 revascularization 的低一个年 mortality.The 需要的一个安全、可行的方法。 | GE Lei John Cosgrave Ioannis Iakovou QIAN Ju-ying Pierfrancesco Agostoni Giuseppe M. Sangiorgi Flavio Airoldi Iassen Michev Alaide Chieffo Nicola Corvaja Antonio Colombo GE Jun-bo | 2007 | Chinese Medical Journal2007，，7： | 5 |
| 2 | Cerebral protection with filter devices during carotid artery stenting显示文摘 | Reimers B Corvaja N Moshiri S | 2001 | Circulation2001，104，： | 1 |
| 3 | Clinical and Angiographic Outcome After Implantation of Drug-Eluting Stents in Bifurcation Lesions With the Crush Stent Technique显示文摘 | Lei Ge Flavio Airoldi Ioannis Iakovou John Cosgrave Iassen Michev Giuseppe M. Sangiorgi Matteo Montorfano Alaide Chieffo Mauro Carlino Nicola Corvaja Antonio Colombo | 2005 | Journal of the American College of Cardiology2005，，4： | 1 |
| 4 | Incidence,predictors,in-hospital,and late outcomes of coronary artery perforations显示文摘 | Stankovic G Orlic D Corvaja N | 2004 | Am J Cardiol2004，93，2： | 1 |
| 5 | New technique to seal a long giant coronary aneurysm with PTFE-covered stents: a case report 显示文摘 | Orlic D Vitrella G Corvaja N | 2006 | Catheter Cardiovasc Interv2006，67，1： | 1 |
| 6 | Cerebral protection with filter devices during carotid artery stenting显示文摘 | Reimers B Corvaja N Moshiri S | 2001 | Circulation2001，104，1： | 1 |
| 7 | Joint channel and phase noise compensation for OFDM in fast-fading multipath applications显示文摘 | CORVAJA R ARMADA A G | 2009 | IEEE Transaction on Vehicular Technology2009，58，2： | 1 |
| 8 | SINR degradation in MIMO-OFDM systems with channel estimation errors and partial phase noise compensation显示文摘 | CORVAJA R ARMADA A G | 2010 | IEEE Trans- actions on Communications2010，58，8： | 1 |
| 9 | Incidence,predictors,in-hospital,and late outcome of coronary artery perforations显示文摘 | Stankovic G Orlic D Corvaja N | 2004 | Am J Cardiol2004，93，： | 1 |
| 10 | New technique to seal a long giant coronary aneurysm with PTFE-covered stents:a case report 显示文摘 | Orlic D Vitrlla G Corvaja N | 2006 | Catheter Cardiovasc Interv2006，67，1： | 1 |
| 11 | Joint channel and phase noise compensation for OFDM Iin fast-fading multipath appli- cations显示文摘 | CORVAJA R ARMADA A G | 2009 | IEEE Transactions on Vehicular Technology2009，58，2： | 1 |
| 12 | Cerebral protection with mter-devices during carotid artery stenting显示文摘 | Reimers B Corvaja N Moshiri S | 2001 | Circulation2001，104，1： | 1 |
| 13 | Cerebral protection with filter devices during carotid artery stenting显示文摘 | Reimers B Corvaja N Moshiri S | 2001 | Circulation2001，104，1： | 1 |
| 14 | Incidence, predictors, in-hospital, and late outcomes of coronary artery perforations显示文摘 | Stankovic G Orlie D Corvaja N | 2004 | Am J Cardiol2004，93，2： | 1 |
| 15 | Cerebral protection with filter devices during carotid artery stenting显示文摘 | Reimers B Corvaja N Moshiri S | 2001 | Circulation2001，104，1： | 1 |
| 16 | Cerebral prptection with filter devices during carotid artery stenting显示文摘 | Corvaja N Moshiri S | 2001 | Circulation2001，104，1： | 1 |
| 17 | Incidence, predictors, in-hospital, and late outcomes of coronary artery perforations显示文摘 | Goran Stankovic Dejan Orlic Nicola Corvaja Flavio Airoldi Alaide Chieffo Vassilis Spanos Matteo Montorfano Mauro Carlino Leo Finci Giuseppe Sangiorgi Antonio Colombo | 2004 | The American Journal of Cardiology2004，，2： | 1 |
| 18 | Cerebral protection with falter devices during carotid artery stenting显示文摘 | Reimers B Corvaja N Moshiri S | 2001 | Circulation2001，104，： | 1 |
| 19 | Winter fine particulate matter from Milan induces morphological and functional alterations in human pulmonary epithelial ceils (A549) 显示文摘 | Gualtieri M Mantecca P Corvaja V | 2009 | Toxicol Lett2009，188，1： | 1 |
| 20 | The use of liquid biopsy in early breast cancer:clinical evidence and future perspectives显示文摘Liquid biopsy,including both circulating tumor cells and circulating tumor DNA,is gaining momentum as a diagnostic modality adopted in the clinical management of breast cancer.Prospective studies testing several technologies demonstrated clinical validity and,in some cases,achieved the United States Food and Drug Administration approval.The initial testing and clinical application of liquid biopsy focused primarily on the diagnosis,while molecular characterization and monitoring of metastatic disease,with larger data from prospective studies,came in the last two decades.Although its role in metastatic setting is thus widely recognized,the current evidence does not provide support for the routine clinical use of liquid biopsy methods for the earlier stage of this disease.Considering the relevance of early detection,characterization,and management of breast cancer in the early-stage,this clinical setting is the most suitable to increase the chances for effective treatment selection and improved prognosis,and a better understanding of the main application of liquid biopsy tools in the earlier stage of breast cancer is therefore crucial.The aim of this review is to provide an overview of the clinical evidence and subsequent potential applications of liquid biopsy in early breast cancer,identifying the main existing caveats and the possible future scenarios. | Paolo D’Amico Carla Corvaja Lorenzo Gerratana Carolina Reduzzi Giuseppe Curigliano Massimo Cristofanilli | 2021 | Journal of Cancer Metastasis and Treatment2021，7，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员